Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Paramount Bed Holdings Co's earnings per share without non-recurring items for the
three
months ended in Sep. 2025 was 円22.02.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2025 was 円42.22.
During the past 12 months, Paramount Bed Holdings Co's average earnings per share (NRI) Growth Rate was -60.60% per year.
During the past 3 years, the average earnings per share (NRI) Growth Rate was 1.20% per year.
During the past 5 years, the average earnings per share (NRI) Growth Rate was 7.60% per year.
During the past 10 years, the average earnings per share (NRI) Growth Rate was 5.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for Paramount Bed Holdings Co's EPS without NRI or its related term are showing as below:
TSE:7817'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -77.8 Med: 9.8 Max: 375.1
Current: 1.2
During the past 13 years, Paramount Bed Holdings Co's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 375.10% per year. The lowest was -77.80% per year. And the median was 9.80% per year.
TSE:7817's 3-Year EPS without NRI Growth Rate is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 8.2
vs TSE:7817: 1.20
Paramount Bed Holdings Co (TSE:7817) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Paramount Bed Holdings Co EPS without NRI Related Terms
Paramount Bed Holdings Co EPS without NRI Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7817 vs ISRG, BDX, MDLN: EPS without NRI Comparison
For the Medical Instruments & Supplies subindustry, Paramount Bed Holdings Co's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paramount Bed Holdings Co PE Ratio without NRI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Paramount Bed Holdings Co's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Paramount Bed Holdings Co's PE Ratio without NRI falls into.
Paramount Bed Holdings Co EPS without NRI Calculation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円42.22
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Paramount Bed Holdings Co (TSE:7817) has a EPS without NRI of 円42.22 as of Sep. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Paramount Bed Holdings Co and its competitors.
Is Paramount Bed Holdings Co's EPS without NRI too high?
Paramount Bed Holdings Co's current EPS without NRI is 円42.22. Overall, Paramount Bed Holdings Co has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Paramount Bed Holdings Co's EPS without NRI compare to ISRG and BDX?
Paramount Bed Holdings Co's EPS without NRI of 円42.22 can be compared against companies in the Medical Devices & Instruments industry. The industry median EPS without NRI is 8.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Devices & Instruments company?
The median EPS without NRI among Medical Devices & Instruments companies is 8.20, based on 661 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Paramount Bed Holdings Co and its competitors. For the Medical Devices & Instruments industry, the median EPS without NRI is 8.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Paramount Bed Holdings Co's current EPS without NRI is 円42.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paramount Bed Holdings Co stock overvalued right now?
Paramount Bed Holdings Co (TSE:7817) has a current EPS without NRI of 円42.22. The stock's GF Value™ is 円2,907.43, compared to a current price of 円3,515.00 — trading 20.9% above its estimated fair value. The current EPS without NRI is 円42.22. Paramount Bed Holdings Co's overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Paramount Bed Holdings Co (TSE:7817), the current EPS without NRI is 円42.22 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Paramount Bed Holdings Co (TSE:7817) Overvalued in 2026?
Based on GuruFocus' analysis, Paramount Bed Holdings Co stock appears to be overvalued.
The current stock price of 円3,515.00 is trading 20.9% above its estimated GF Value™ of 円2,907.43.
Key valuation signals for TSE:7817:
EPS without NRI: 円42.22
GF Value™: 円2,907.43 vs. price of 円3,515.00 (20.9% above fair value)
No single metric tells the full story. See the TSE:7817 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Paramount Bed Holdings Co Ltd manufactures medical and nursing care products. Its acute care business sells products to intensive care units and other acute care facilities to relieve patient discomfort and prevent secondary infections. The long-term care business sells products used at long-term medical care facilities and nursing homes. The residential and nursing care business sells products to nurses and home-care helpers. The sleep and wellness business sells products to help customers sleep soundly, which include custom-made mattresses. The maintenance business provides bed maintenance and cleaning services. Paramount Bed generates the vast majority of its revenue in Japan.
69GF Score
Get the complete analysis for TSE:7817
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7817 has been successfully added to your 
